Markets

Market Nav

News Details

27/04/2026 20:28

Emcure Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 201

Update on appointment of Mr. C S Muralidharan, Independent Director